These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28400196)

  • 1. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
    Gonsky R; Fleshner P; Deem RL; Biener-Ramanujan E; Li D; Potdar AA; Bilsborough J; Yang S; McGovern DPB; Targan SR
    Gastroenterology; 2017 Jul; 153(1):219-232. PubMed ID: 28400196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic potential of RNASET2 in Crohn's disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion.
    Biener-Ramanujan E; Rosier F; Coetzee SG; McGovern DDP; Hazelett D; Targan SR; Gonsky R
    Front Immunol; 2022; 13():999155. PubMed ID: 36466822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFNG rs1861494 polymorphism is associated with IBD disease severity and functional changes in both IFNG methylation and protein secretion.
    Gonsky R; Deem RL; Landers CJ; Haritunians T; Yang S; Targan SR
    Inflamm Bowel Dis; 2014 Oct; 20(10):1794-801. PubMed ID: 25171510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
    Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
    J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease.
    Richard AC; Peters JE; Savinykh N; Lee JC; Hawley ET; Meylan F; Siegel RM; Lyons PA; Smith KGC
    PLoS Genet; 2018 Sep; 14(9):e1007458. PubMed ID: 30199539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.
    Michelsen KS; Thomas LS; Taylor KD; Yu QT; Mei L; Landers CJ; Derkowski C; McGovern DP; Rotter JI; Targan SR
    PLoS One; 2009; 4(3):e4719. PubMed ID: 19262684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells.
    Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G
    Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
    Prehn JL; Mehdizadeh S; Landers CJ; Luo X; Cha SC; Wei P; Targan SR
    Clin Immunol; 2004 Jul; 112(1):66-77. PubMed ID: 15207783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population.
    Lan X; Lan X; Chang Y; Zhang X; Liu J; Vikash V; Wang W; Huang M; Wang X; Zhou F; Chen L; Zhao Q
    Cell Physiol Biochem; 2017; 41(5):2077-2090. PubMed ID: 28456797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis.
    Barrett R; Zhang X; Koon HW; Vu M; Chang JY; Yeager N; Nguyen MA; Michelsen KS; Berel D; Pothoulakis C; Targan SR; Shih DQ
    Am J Pathol; 2012 Feb; 180(2):636-49. PubMed ID: 22138299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.
    Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
    Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TNF family member TL1A induces IL-22 secretion in committed human T
    Thomas LS; Targan SR; Tsuda M; Yu QT; Salumbides BC; Haritunians T; Mengesha E; McGovern DP; Michelsen KS
    J Leukoc Biol; 2017 Mar; 101(3):727-737. PubMed ID: 27733581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens.
    Gonsky R; Deem RL; Landers CJ; Derkowski CA; Berel D; McGovern DP; Targan SR
    Inflamm Bowel Dis; 2011 Jan; 17(1):171-8. PubMed ID: 20848535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-543-3p promotes locomotor function recovery after spinal cord injury by inhibiting the expression of tumor necrosis factor superfamily member 15 in rats.
    Li XZ; Lv CL; Shi JG; Zhang CX
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2701-2709. PubMed ID: 31002119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
    Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis.
    Shih DQ; Barrett R; Zhang X; Yeager N; Koon HW; Phaosawasdi P; Song Y; Ko B; Wong MH; Michelsen KS; Martins G; Pothoulakis C; Targan SR
    PLoS One; 2011 Jan; 6(1):e16090. PubMed ID: 21264313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.